Abbott Laboratories Launches Ensure Max Protein Shakes for Older Adults' Muscle Health
- Abbott Laboratories introduces Ensure Max Protein shakes to enhance muscle health in older adults.
- The shakes provide essential nutrients to combat age-related muscle mass decline.
- Abbott emphasizes the importance of nutrition for maintaining strength and vitality in aging populations.
Abbott Laboratories Launches New Protein Shakes to Support Muscle Health in Older Adults
Abbott Laboratories, a leader in science-based nutrition, takes a significant step toward enhancing muscle health among older adults with the introduction of two new products in its Ensure Max Protein line. The new shakes, Ensure Max Protein 42g and Ensure Max Protein 2 in 1 Muscle Support, are specifically designed to combat the natural decline in muscle mass that occurs after the age of 40. Research indicates that individuals can lose up to 8% of muscle mass per decade, making this initiative particularly relevant for the aging population. These shakes not only aim to provide essential nutrients but also promote an active lifestyle, empowering older adults to maintain their strength and mobility.
The Ensure Max Protein 42g shake is tailored for active adults and boasts an impressive formulation of 42 grams of complete protein, along with 23 vitamins and minerals, and two key electrolytes. This combination is intended to support muscle function, especially when paired with resistance training. On the other hand, the Ensure Max Protein 2 in 1 Muscle Support shake focuses on older adults who may require additional assistance to maintain muscle mass. It contains 30 grams of protein and 1.5 grams of CaHMB, a compound shown to help slow muscle breakdown. Both shakes underscore Abbott's commitment to addressing the nutritional needs that emerge with aging, reflecting a proactive approach to health management for older individuals.
The launch of these shakes is endorsed by Matt Ryan, former professional quarterback and MVP, who highlights the integral role of muscle health in achieving overall strength and mobility as one ages. Ryan's participation aims to inspire adults to prioritize their muscle health, encouraging them to set ambitious wellness goals. This collaboration not only elevates the conversation around muscle maintenance but also emphasizes that aging should not equate to physical decline; rather, it can be viewed as an opportunity to embrace vitality and an active lifestyle. Additionally, emerging data suggest that increased protein intake may assist in stabilizing glucose levels, further enhancing the long-term health benefits associated with these products.
In summary, Abbott Laboratories showcases its dedication to improving the quality of life for older adults by addressing the critical issue of muscle health through innovative nutritional solutions. The Ensure Max Protein line not only empowers individuals to take charge of their health but also reinforces the notion that aging can be synonymous with strength and vitality. As Abbott continues to focus on science-based nutrition, its efforts inspire a healthier, more active population, regardless of age.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

